Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

Abstract Background Until 50% of patients with renal cancer or melanoma, develop brain metastases during the course of their disease. Stereotactic radiotherapy has become a standard of care for patients with a limited number of brain metastases. Given the radioresistant nature of melanoma and renal...

Full description

Bibliographic Details
Main Authors: Paul Lesueur, Justine Lequesne, Victor Barraux, William Kao, Julien Geffrelot, Jean-Michel Grellard, Jean-Louis Habrand, Evelyne Emery, Brigitte Marie, Juliette Thariat, Dinu Stefan
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Radiation Oncology
Subjects:
Stereotactic radiotherapy
Brain metastases
Radioresistant
Melanoma
Fractionation
Renal Cancer
Online Access:http://link.springer.com/article/10.1186/s13014-018-1083-1

Internet

http://link.springer.com/article/10.1186/s13014-018-1083-1

Similar Items